Due to a systematic review, four studies involving two studies on rectal cancer, a study on breast cancer, and another single study on esophageal cancer have evaluated the changes in the expression level of CTLA-4 in the TME after CRT or NCT alone until January 2019. The gene discussed is CTLA4; the disease is breast carcinoma.